Femtech Startup Tuune Secures $4.6 Million In Financing To Launch In The U.S., Paving The Way For Personalized Birth Control
Oct 06, 2021•almost 4 years ago
Amount Raised
$4.6 Million
Round Type
seed
Description
Tuune, a femtech startup revolutionizing women’s health by offering individualized hormonal analysis and birth control, today announced the closing of a $4.6M fundraising round to launch in the U.S. market. The investment, led by venture capital firm Octopus Ventures, will support Tuune’s efforts to build a more individualized medical system that puts hormones first, transforming the future of healthcare for all women and people with cycles.